Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3571 AL 3585

Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease

Jia J, Ji Y, Feng T, Ye Q, Peng D, Kuang W, Ning Y, Liang Z, Fan D, Wei W, Li Y, Xiao S.

J Alzheimers Dis. 2019;72(4):1313-1322. doi: 10.3233/JAD-190791.

Madelung's Disease Leading to Presenile Dementia in a Non-alcoholic Patient

El Hasbani G, Assaker R, Nithisoontorn S, Plath W, Lopez EO, Gamarra JV, Kofahi A, Bertely C, Dimitrov V.

Med Arch. 2019 Aug;73(4):285-287. doi: 10.5455/medarh.2019.73.285-287.

Development of Near-Infrared Fluorescent Probes for Use in Alzheimer's Disease Diagnosis

Yang J, Zeng F, Ge Y, Peng K, Li X, Li Y, Xu Y.

Bioconjug Chem. 2020 Jan 15;31(1):2-15. doi: 10.1021/acs.bioconjchem.9b00695. Epub 2019 Dec 16.

Salvage of the retinal ganglion cells in transition phase in Alzheimer's disease with topical coenzyme Q10: is it possible?

Karakahya RH, Özcan TŞ.

Graefes Arch Clin Exp Ophthalmol. 2020 Feb;258(2):411-418. doi: 10.1007/s00417-019-04544-3. Epub 2019 Nov 28.

Cognitive symptoms of Alzheimer's disease: clinical management and prevention

Joe E, Ringman JM.

BMJ. 2019 Dec 6;367:l6217. doi: 10.1136/bmj.l6217.

Arterial Spin Labeling Magnetic Resonance Imaging in the Assessment of Non-Convulsive Status Epilepticus in Alzheimer's Disease: A Report of Two Cases

Mutoh T, Eguchi K, Yamamoto S, Yasui N, Taki Y.

Am J Case Rep. 2019 Dec 16;20:1883-1887. doi: 10.12659/AJCR.919938.

Current and Emerging Solutions to Challenges in the Management of Alzheimer's Disease

Atri A, Goldfarb D, Sheard S, Shaughnessy L.

J Clin Psychiatry. 2019 Dec 3;80(6):MS18002AH3C. doi: 10.4088/JCP.MS18002AH3C.

Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies

Avgerinos KI, Egan JM, Mattson MP, Kapogiannis D.

Ageing Res Rev. 2020 Mar;58:101001. doi: 10.1016/j.arr.2019.101001. Epub 2019 Dec 20.

Biological applications of near infrared fluorescence dye probes in monitoring Alzheimer's disease

Gyasi YI, Pang YP, Li XR, Gu JX, Cheng XJ, Liu J, Xu T, Liu Y.

Eur J Med Chem. 2020 Feb 1;187:111982. doi: 10.1016/j.ejmech.2019.111982. Epub 2019 Dec 19.

Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases

Páez JA, Campillo NE.

Curr Med Chem. 2019;26(18):3300-3340. doi: 10.2174/0929867325666180226095132.

Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research

Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Vergallo A, Farlow MR, Snyder PJ, Giacobini E, Khachaturian ZS.

J Prev Alzheimers Dis. 2019;6(1):2-15. doi: 10.14283/jpad.2018.43.

The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease

Rubin LH, Sundermann EE, Moore DJ.

J Neurovirol. 2019 Oct;25(5):661-672. doi: 10.1007/s13365-018-0702-9. Epub 2019 Jan 22.

PPAR-δ and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism

Altinoz MA, Ozpinar A.

Int Immunopharmacol. 2019 Apr;69:245-256. doi: 10.1016/j.intimp.2019.01.057. Epub 2019 Feb 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias